Results 191 to 200 of about 1,567,396 (295)

Beyond Conventional Cost–Benefit Analysis to Integrated Sustainability Assessment in Additive Manufacturing

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Additive manufacturing (AM) adoption provides numerous benefits, including decentralised production, design flexibility, mass customisation, reduced material waste and lightweight designs. However, AM investment decisions are complex and challenging for manufacturers, and limited knowledge exists about the holistic assessment of relevant costs
Dilupa Nakandala   +5 more
wiley   +1 more source

Pros and cons of sociality across ecological niches: a swarm robotics approach. [PDF]

open access: yesFront Psychol
Miletitch R   +3 more
europepmc   +1 more source

Laminar Burning Velocity of Ammonia‐Hydrogen Mixtures Predicted by Machine Learning

open access: yesChemie Ingenieur Technik, EarlyView.
Ammonia–hydrogen blends aid defossilization, but slow combustion kinetics require complex modeling. Although chemical kinetic modeling is computationally expensive, machine learning surrogates offer fast predictions. This study trained GPR, DT, and ANN models on 1445 experimental points.
Georg Klepp   +2 more
wiley   +1 more source

Umbilical Cord: A Non-Invasive DNA Source for Sea Turtle Genomics. [PDF]

open access: yesMol Ecol Resour
Marín-Capuz G   +4 more
europepmc   +1 more source

Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with Berzosertib

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Repurposing drugs whose clinical safety has been established offers a valuable approach to reduce the cost and time associated with the development of new drugs for malaria. Here, we investigate the potential to repurpose the anticancer kinase inhibitor berzosertib for the treatment of malaria, by assessing whether a predicted efficacious human dose ...
Devasha Redhi   +5 more
wiley   +1 more source

A Practical Guide to Implementing Real‐World Evidence as Primary Basis for Approval and Label Expansion

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
In June 2026, the FDA issued a revised draft guidance describing the circumstances in which one adequate and well‐controlled clinical investigation plus confirmatory evidence may satisfy the statutory substantial evidence standard for establishing efficacy and safety. Confirmatory evidence includes real‐world evidence (RWE).
Tracy J. Mayne   +2 more
wiley   +1 more source

Aggressive conflict used as landmark information in homing desert ants. [PDF]

open access: yesJ Exp Biol
Bollig A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy